Government urged to activate substitute drug dispensing through scrapping of post-dispensing notice

Published: 2003-09-25 06:58:00

Updated: 2003-09-25 06:58:00

Rep. Kim Sung-soon, a member of the National Assembly's Health and Welfare Committee insisted during a parliamentary inspection session to the Korea Food and Drug Administration that the government should scrap the current post-dispensing notice on bioequivalence-tested drugs to discourage the ex...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK